Explore compound KLOW$155.00
Skip to content
RESEARCH, REFINED.
The details
Considered compounds. Documented standards.Explore our standard
RESEARCH, REFINED.Radiance research
GLOW
70 mg / $130.00
GLOW is a co-lyophilized research blend that assembles three complementary tissue-remodeling references into a single vial: GHK-Cu (copper tripeptide-1), BPC-157, and TB-500.
Available formats
1
Availability and final pricing are checked at checkout.
1 laboratory report availableFor laboratory research use only. Not for human consumption.
A closer look
The details
behind the compound.
Overview
GLOW is a co-lyophilized research blend that assembles three complementary tissue-remodeling references into a single vial: GHK-Cu (copper tripeptide-1), BPC-157, and TB-500. Its copper-tripeptide-dominant composition gives the powder a characteristic pale-blue tint.
It is studied for the combined signaling characteristics of its constituents in comparative models, consolidating three gold-standard references into one acquisition for laboratory convenience.
Laboratory documentation
Check the product format and report identifiers before comparing results. Available reports do not establish the lot currently held in stock.
Freedom Diagnostics2026-03-07 · Analysis report · Lot 20260303glo99.573%Research references
Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in light of new gene data. Int J Mol Sci. 2018.
Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation. J Mol Med. 2017.
Storage & handling
Store the lyophilized blend at −20°C for long-term stability. Reconstituted solution is held cold and used within a short window; avoid chelating agents, which can strip copper from the GHK-Cu component.
